Oct 29, 2026 earnings call — Repayments accelerate portfolio repositioning
KREF reported $2.4 billion of year-to-date repayments, surpassing its $2 billion expectation for the year.
Revenue $0.0B (est $0.0B) · EPS $-0.11 (est $-0.31)
Key quotes
"Portfolio repayment activity has been particularly strong, with $2.4 billion of repayments year to date, surpassing our $2 billion expectation for the year."
"Strong repayment activity during the quarter also drove a meaningful reduction in leverage, with our debt-to-equity ratio declining from 2.6x-2.2x, and total leverage declining from 4.3x-3.1x below our historical target range, and we expect leverage to remain below the historical range for the fourth quarter."
Analyst Q&A 5
reserves for uncertain loan values
Q (Tom Catherwood · BTIG): He asked why the company does not take worst-case marks now — is it lack of market comps or something else? He also asked whether more legacy loans (especially multifamily) will need modifications or reserves.
A: Management said markets are opaque and some markets are illiquid, so they are marking loans and holding CECL reserves appropriate to current market conditions. They will adjust reserves in real time as resolution processes advance. They are watching multifamily, especially 2021 and 2022 vintages, where values are down and some loans are close to the line.
"We obviously are marking these and have CECL reserves appropriate for what we are seeing in the market today." — Matt Salem (CEO)
Boston life science loan outcome
Q (Jade Rahmani · KBW): She asked what happened to the Boston Life Science loan — was it sold or acquired? She also asked about multifamily: percent pre-2023 vintages, in-place debt yields, whether 5.5%-6% debt yield implies KREF would absorb a loss, and whether KREF might hold REO with leverage instead of selling.
A: Patrick said the Boston Life Science loan had non-recourse financing and, as values changed, they assigned the loan back to the lender; KREF recorded a loss on its portion and the loan is removed from the portfolio. Matt said he did not have the exact percent of 2021/2022 multifamily on hand and would follow up, and that 5.5%-6% debt yields need to be judged by market growth and sponsor liquidity; he also said they evaluate all options for REO, citing a Raleigh multifamily example where they stabilized operations and later sold, but they do not see a large wave of similar opportunities.
"What you see reflected in this quarter was the loss on our portion of that loan, and it is obviously removed from the portfolio at this point." — Patrick Mattson (COO)
market activity and leverage level
Q (Rick Shane · JPMorgan): He asked if KREF will be active in the market given high liquidity but leverage below target, and how management keeps employees motivated during strategic review. He also asked why buybacks slowed and whether the strategic review affected buyback cadence.
A: Management said they are active participants in the market and originated two loans this quarter. They said the investing team also works for other KKR pools, so employee motivation is not an issue. They noted heavy end-of-quarter repayments reduced leverage and that the strategic review affected buyback activity after the announcement.
"I guess just to be direct, 100% we are active participants in the market." — Matt Salem (CEO)
why higher rates don't help profits
Q (Chris Muller · Citizens): He asked why higher interest rates do not provide a bigger benefit to the company's bottom line. He also asked what the strategic review expenses include and whether they are ongoing or one-time.
A: Patrick said benefits from higher rates are limited because many loans have floors and floating-rate debt outstanding is roughly similar in size to floating-rate loan assets, and REO assets do not produce income. Kendra said strategic review costs are mainly financial and legal advisors, the expenses are ongoing, they were back-ended in Q3, and will grow on a full-quarter basis in Q4.
"The other factor is just that if you look at our debt outstanding that's subject to a floating rate and look at our loan assets outstanding that are subject to a floating rate, they're fairly close to each other." — Patrick Mattson (COO)
what KKR is doing in real estate
Q (Gabe Poggi · Raymond James): He asked what KKR is doing across commercial real estate now, which sectors or activities they find interesting, and any color on deals like the life science JV with Alexandria and other capital outside the REIT.
A: Management said on the debt side KKR remains active across its capital pools and views the lending environment as attractive. They are focused on multifamily and industrial lending, are also active in senior housing (originated a loan this quarter), and see potential equity opportunities in multifamily value-add as supply comes down.
"You saw in this quarter we did originate a loan within KREF on senior housing." — Matt Salem (CEO)